Kleanthis G. Xanthopoulos, Director at APRICUS BIOSCIENCES, INC. (APRI), sold 3,125 shares at $3.25 ($10K) on 2012-09-28, disclosed to the SEC on 2012-10-01.
Scheduled sale ($10k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RGLS | SELL | 2015-03-05 | $1.8M | — | Filing → |
| RGLS | SELL | 2015-03-03 | $1K | — | Filing → |
| RGLS | SELL | 2015-02-03 | $112K | — | Filing → |